TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% |
Q3 2021 | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% |
Q2 2021 | $582,000 | -19.5% | 15,000 | 0.0% | 0.35% | -18.9% |
Q1 2021 | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% |
Q4 2020 | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
Q3 2020 | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
Q2 2020 | $292,000 | +97.3% | 15,000 | 0.0% | 0.18% | +34.4% |
Q1 2020 | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% |
Q4 2019 | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% |
Q3 2019 | $84,000 | -35.4% | 15,000 | 0.0% | 0.06% | -29.1% |
Q2 2019 | $130,000 | +7.4% | 15,000 | 0.0% | 0.08% | +3.9% |
Q1 2019 | $121,000 | +95.2% | 15,000 | 0.0% | 0.08% | +28.8% |
Q4 2018 | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% |
Q3 2018 | $84,000 | -57.4% | 15,000 | 0.0% | 0.05% | -59.7% |
Q2 2018 | $197,000 | – | 15,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |